Related references
Note: Only part of the references are listed.Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation
Diptadip Dattaroy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design
Scott Friedman et al.
CONTEMPORARY CLINICAL TRIALS (2016)
Innate Immunity and Inflammation in NAFLD/NASH
Marco Arrese et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Herbert Tilg et al.
HEPATOLOGY (2016)
Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9
Irma Garcia-Martinez et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome
Nancy E. Aguilar-Olivos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Management of NAFLD: a stage-based approach
Mary E. Rinella et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD
Newaz Hossain et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis
Chrysi Koliaki et al.
CELL METABOLISM (2015)
Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshihisa Takahashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies
Hui Liu et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2014)
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
Alexander Wree et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation
Soo Jin Yang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Toll-Like Receptor 2 and Palmitic Acid Cooperatively Contribute to the Development of Nonalcoholic Steatohepatitis Through Inflammasome Activation in Mice
Kouichi Miura et al.
HEPATOLOGY (2013)
Immune and inflammatory pathways in NASH
Michal Ganz et al.
HEPATOLOGY INTERNATIONAL (2013)
Docosahexaenoic acid ameliorates palmitate-induced lipid accumulation and inflammation through repressing NLRC4 inflammasome activation in HepG2 cells
Xiaoqin Luo et al.
NUTRITION & METABOLISM (2012)
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
Paul M. Ridker et al.
AMERICAN HEART JOURNAL (2011)
Innate Immunity and Steatohepatitis: A Critical Role of Another Toll (TLR-9)
Bin Gao
GASTROENTEROLOGY (2010)
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Kouichi Miura et al.
GASTROENTEROLOGY (2010)
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Qin Zhang et al.
NATURE (2010)
Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome
Avlin B. Imaeda et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats
Veysel Tahan et al.
JOURNAL OF PINEAL RESEARCH (2009)
Current concepts in the pathogenesis of nonalcoholic fatty liver disease
Nahum Mendez-Sanchez et al.
LIVER INTERNATIONAL (2007)
Toll-like receptors and innate immunity
R Medzhitov
NATURE REVIEWS IMMUNOLOGY (2001)
Share Paper
